Steve Cohen: portfolio of Point72 Asset Management
Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary Amended on May 15, 2023 – the version known today is shown.
You are looking at Q4 2022. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 26.0B USD
- Positions
- 1,022
- Share of the ten largest
- 14.3%
The ten largest positions Q4 2022
- Meta Platforms 2.2%▲ +140.7%
- Broadcom 1.7%▲ +166.0%
- Salesforce 1.7%new
- Amazon 1.6%▲ +174.8%
- Fidelity National Information Services 1.6%▲ +81.6%
- Biogen 1.3%▼ −26.9%
- Visa Inc. 1.2%▲ +32.7%
- Take-Two Interactive 1.1%▲ +80.1%
- Uber 0.9%▲ +18,546.7%
- Dominion Energy 0.9%▲ +197.1%
Show all positions of this quarter
Choose a quarter (50 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
All positions Q4 2022
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| BIIB Biogen | 1.3% | 1,226,124 | 339.5M USD | −26.9% reduced | Q3 2020 10 quarters |
| ADI Analog Devices | 0.9% | 1,355,581 | 222.4M USD | −4.7% reduced | Q2 2020 11 quarters |
| ANET Arista Networks | 0.8% | 1,812,261 | 219.9M USD | −8.4% reduced | Q1 2021 8 quarters |
| BABA Alibaba Group (ADR) | 0.7% | 2,150,552 | 189.4M USD | −39.1% reduced | Q4 2021 5 quarters |
| ZBH Zimmer Biomet | 0.6% | 1,138,053 | 145.1M USD | −11.6% reduced | Q1 2022 4 quarters |
| YUM Yum! Brands | 0.5% | 1,075,502 | 137.8M USD | −10.2% reduced | Q1 2022 4 quarters |
| MSFT Microsoft | 0.5% | 505,525 | 121.2M USD | −47.2% reduced | Q1 2020 12 quarters |
| JBL Jabil | 0.5% | 1,776,900 | 121.2M USD | −13.9% reduced | Q2 2019 15 quarters |
| ORCL Oracle Corporation | 0.5% | 1,482,512 | 121.2M USD | −50.7% reduced | Q1 2022 4 quarters |
| AZN AstraZeneca | 0.4% | 1,539,490 | 104.4M USD | −68.0% reduced | Q1 2020 12 quarters |
| Inspire Med Sys Inc | 0.4% | 412,924 | 104.0M USD | −15.5% reduced | Q4 2020 9 quarters |
| MLM Martin Marietta Materials | 0.4% | 282,253 | 95.4M USD | −5.4% reduced | Q1 2021 8 quarters |
| Sarepta Therapeutics Inc | 0.4% | 703,755 | 91.2M USD | −17.4% reduced | Q1 2021 8 quarters |
| EL Estée Lauder Companies (The) | 0.3% | 360,707 | 89.5M USD | −31.1% reduced | Q1 2022 4 quarters |
| CB Chubb Limited | 0.3% | 387,634 | 85.5M USD | −8.4% reduced | Q2 2020 11 quarters |
| INTU Intuit | 0.3% | 202,055 | 78.6M USD | −23.7% reduced | Q3 2022 2 quarters |
| Canadian Nat Res Ltd | 0.3% | 1,409,900 | 78.3M USD | −26.1% reduced | Q1 2022 4 quarters |
| LVS Las Vegas Sands | 0.3% | 1,502,803 | 72.2M USD | −31.7% reduced | Q3 2018 18 quarters |
| TDY Teledyne Technologies | 0.3% | 176,628 | 70.6M USD | −6.7% reduced | Q3 2020 10 quarters |
| Antero Resources Corp | 0.3% | 2,256,115 | 69.9M USD | −2.9% reduced | Q3 2020 10 quarters |
| Anaptysbio Inc | 0.3% | 2,124,200 | 65.8M USD | −15.9% reduced | Q4 2021 5 quarters |
| Restaurant Brands Intl Inc | 0.3% | 1,007,245 | 65.1M USD | −29.5% reduced | Q3 2022 2 quarters |
| VMC Vulcan Materials Company | 0.2% | 361,626 | 63.3M USD | −12.6% reduced | Q1 2021 8 quarters |
| CRWD CrowdStrike | 0.2% | 600,220 | 63.2M USD | −37.7% reduced | Q4 2021 5 quarters |
| SHW Sherwin-Williams | 0.2% | 262,850 | 62.4M USD | −4.5% reduced | Q2 2022 3 quarters |
| VST Vistra Corp. | 0.2% | 2,666,835 | 61.9M USD | −3.9% reduced | Q1 2021 8 quarters |
| Fortune Brands Innovations I | 0.2% | 1,033,220 | 59.0M USD | −24.4% reduced | Q2 2021 7 quarters |
| Exact Sciences Corp | 0.2% | 1,173,909 | 58.1M USD | −51.7% reduced | Q3 2022 2 quarters |
| Stellantis N.v | 0.2% | 4,015,899 | 57.0M USD | −3.7% reduced | Q1 2022 4 quarters |
| UNP Union Pacific Corporation | 0.2% | 269,699 | 55.8M USD | −32.2% reduced | Q3 2022 2 quarters |
| CSCO Cisco | 0.2% | 1,164,965 | 55.5M USD | −42.8% reduced | Q3 2022 2 quarters |
| MNST Monster Beverage | 0.2% | 543,029 | 55.1M USD | −72.6% reduced | Q3 2021 6 quarters |
| Bellring Brands Inc | 0.2% | 2,144,220 | 55.0M USD | −2.4% reduced | Q1 2022 4 quarters |
| CRDO Credo Technology Group | 0.2% | 3,813,700 | 50.8M USD | −4.0% reduced | Q1 2022 4 quarters |
| TMUS T-Mobile US | 0.2% | 357,008 | 50.0M USD | −84.4% reduced | Q2 2020 11 quarters |
| RMD ResMed | 0.2% | 234,425 | 48.8M USD | −41.1% reduced | Q1 2022 4 quarters |
| Macys Inc | 0.2% | 2,304,731 | 47.6M USD | −54.7% reduced | Q2 2022 3 quarters |
| Xenon Pharmaceuticals Inc | 0.2% | 1,178,324 | 46.5M USD | −28.2% reduced | Q1 2015 32 quarters |
| Amedisys Inc | 0.2% | 551,468 | 46.1M USD | −48.5% reduced | Q3 2022 2 quarters |
| Ambarella Inc | 0.2% | 557,248 | 45.8M USD | −56.9% reduced | Q3 2021 6 quarters |
| Ascendis Pharma A/S | 0.2% | 374,710 | 45.8M USD | −2.5% reduced | Q3 2022 2 quarters |
| Chord Energy Corporation | 0.2% | 333,418 | 45.6M USD | −5.6% reduced | Q4 2021 5 quarters |
| HII Huntington Ingalls Industries | 0.2% | 192,900 | 44.5M USD | −5.9% reduced | Q4 2021 5 quarters |
| Krystal Biotech Inc | 0.2% | 556,252 | 44.1M USD | −55.8% reduced | Q2 2020 11 quarters |
| Avantor Inc | 0.2% | 2,069,355 | 43.6M USD | −11.8% reduced | Q1 2020 12 quarters |
| Victorias Secret And Co | 0.2% | 1,204,768 | 43.1M USD | −24.0% reduced | Q3 2021 6 quarters |
| MRK Merck & Co. | 0.2% | 352,873 | 39.2M USD | −40.7% reduced | Q2 2020 11 quarters |
| LUV Southwest Airlines | 0.1% | 1,158,193 | 39.0M USD | −57.4% reduced | Q4 2021 5 quarters |
| Healthequity Inc | 0.1% | 632,425 | 39.0M USD | −6.8% reduced | Q4 2021 5 quarters |
| MAT Mattel | 0.1% | 2,178,742 | 38.9M USD | −10.9% reduced | Q3 2020 10 quarters |
| Molina Healthcare Inc | 0.1% | 115,800 | 38.2M USD | −33.3% reduced | Q3 2022 2 quarters |
| Uniqure NV | 0.1% | 1,672,830 | 37.9M USD | −60.7% reduced | Q2 2020 11 quarters |
| AEE Ameren | 0.1% | 419,979 | 37.3M USD | −40.0% reduced | Q1 2022 4 quarters |
| HLT Hilton Worldwide | 0.1% | 287,364 | 36.3M USD | −62.7% reduced | Q4 2021 5 quarters |
| WAT Waters Corporation | 0.1% | 105,522 | 36.1M USD | −11.4% reduced | Q1 2022 4 quarters |
| BRO Brown & Brown | 0.1% | 625,404 | 35.6M USD | −21.5% reduced | Q2 2022 3 quarters |
| Valvoline Inc | 0.1% | 1,071,000 | 35.0M USD | −14.2% reduced | Q3 2021 6 quarters |
| Chinook Therapeutics Inc | 0.1% | 1,267,660 | 33.2M USD | −48.1% reduced | Q4 2020 9 quarters |
| Mastec Inc | 0.1% | 379,200 | 32.4M USD | −37.1% reduced | Q3 2022 2 quarters |
| Shell PLC | 0.1% | 527,400 | 30.0M USD | −37.9% reduced | Q1 2022 4 quarters |
| Bicycle Therapeutics PLC | 0.1% | 1,007,978 | 29.8M USD | −19.7% reduced | Q4 2019 13 quarters |
| Haemonetics Corp Mass | 0.1% | 373,846 | 29.4M USD | −32.9% reduced | Q2 2022 3 quarters |
| Enerplus Corp | 0.1% | 1,650,519 | 29.1M USD | −28.8% reduced | Q4 2018 17 quarters |
| Foot Locker Inc | 0.1% | 750,071 | 28.3M USD | −18.7% reduced | Q3 2022 2 quarters |
| Aclaris Therapeutics Inc | 0.1% | 1,782,600 | 28.1M USD | −3.8% reduced | Q1 2021 8 quarters |
| GM General Motors | 0.1% | 820,690 | 27.6M USD | −80.1% reduced | Q2 2020 11 quarters |
| Juniper Networks Inc | 0.1% | 827,211 | 26.4M USD | −86.8% reduced | Q3 2021 6 quarters |
| IBKR Interactive Brokers | < 0.1% | 357,400 | 25.9M USD | −10.7% reduced | Q2 2022 3 quarters |
| Insmed Inc | < 0.1% | 1,291,580 | 25.8M USD | −16.2% reduced | Q3 2018 18 quarters |
| Corebridge Finl Inc | < 0.1% | 1,273,754 | 25.6M USD | −26.4% reduced | Q3 2022 2 quarters |
| Jack In The Box Inc | < 0.1% | 361,404 | 24.7M USD | −51.6% reduced | Q3 2022 2 quarters |
| Sanofi | < 0.1% | 500,000 | 24.2M USD | −71.1% reduced | Q1 2018 20 quarters |
| Pbf Energy Inc | < 0.1% | 588,600 | 24.0M USD | −14.4% reduced | Q1 2022 4 quarters |
| ETR Entergy | < 0.1% | 212,568 | 23.9M USD | −56.5% reduced | Q1 2022 4 quarters |
| Fluor Corp New | < 0.1% | 680,000 | 23.6M USD | −53.0% reduced | Q2 2022 3 quarters |
| Point Biopharma Global Inc | < 0.1% | 3,197,565 | 23.3M USD | −13.4% reduced | Q1 2022 4 quarters |
| DXCM Dexcom | < 0.1% | 202,835 | 23.0M USD | −75.6% reduced | Q2 2022 3 quarters |
| APTV Aptiv | < 0.1% | 245,508 | 22.9M USD | −72.3% reduced | Q4 2021 5 quarters |
| NI NiSource | < 0.1% | 792,600 | 21.7M USD | −57.6% reduced | Q3 2022 2 quarters |
| GDDY GoDaddy | < 0.1% | 289,861 | 21.7M USD | −68.4% reduced | Q3 2021 6 quarters |
| Quidelortho Corp | < 0.1% | 251,400 | 21.5M USD | −76.8% reduced | Q2 2022 3 quarters |
| FANG Diamondback Energy | < 0.1% | 148,299 | 20.3M USD | −21.7% reduced | Q3 2022 2 quarters |
| Floor & Decor HLDGS Inc | < 0.1% | 283,594 | 19.7M USD | −58.8% reduced | Q3 2022 2 quarters |
| APD Air Products | < 0.1% | 63,870 | 19.7M USD | −68.9% reduced | Q1 2022 4 quarters |
| Aecom | < 0.1% | 227,200 | 19.3M USD | −44.3% reduced | Q3 2021 6 quarters |
| LII Lennox International | < 0.1% | 77,700 | 18.6M USD | −56.0% reduced | Q4 2021 5 quarters |
| Sensata Technologies Hldg Pl | < 0.1% | 459,439 | 18.6M USD | −8.9% reduced | Q2 2022 3 quarters |
| Allete Inc | < 0.1% | 287,200 | 18.5M USD | −16.3% reduced | Q2 2020 11 quarters |
| East West Bancorp Inc | < 0.1% | 280,804 | 18.5M USD | −46.3% reduced | Q1 2022 4 quarters |
| Select Sector SPDR TR | < 0.1% | 210,000 | 18.4M USD | −90.0% reduced | Q1 2019 16 quarters |
| RSG Republic Services | < 0.1% | 140,433 | 18.1M USD | −27.3% reduced | Q2 2022 3 quarters |
| Axogen Inc | < 0.1% | 1,815,000 | 18.1M USD | −16.2% reduced | Q2 2022 3 quarters |
| Marqeta Inc | < 0.1% | 2,950,000 | 18.0M USD | −12.8% reduced | Q4 2021 5 quarters |
| PSA Public Storage | < 0.1% | 64,261 | 18.0M USD | −50.6% reduced | Q2 2022 3 quarters |
| EVRG Evergy | < 0.1% | 278,600 | 17.5M USD | −12.6% reduced | Q3 2022 2 quarters |
| SPDR S&P 500 ETF TR | < 0.1% | 44,000 | 16.8M USD | −35.3% reduced | Q1 2022 4 quarters |
| Elastic N V | < 0.1% | 324,965 | 16.7M USD | −26.9% reduced | Q2 2020 11 quarters |
| AME Ametek | < 0.1% | 119,302 | 16.7M USD | −15.4% reduced | Q3 2021 6 quarters |
| Health Catalyst Inc | < 0.1% | 1,566,000 | 16.6M USD | −18.8% reduced | Q1 2022 4 quarters |
| Netstreit Corp | < 0.1% | 905,595 | 16.6M USD | −9.9% reduced | Q1 2022 4 quarters |
| Arcutis Biotherapeutics Inc | < 0.1% | 1,103,576 | 16.3M USD | −70.8% reduced | Q3 2020 10 quarters |
| Dyne Therapeutics Inc | < 0.1% | 1,387,668 | 16.1M USD | −7.3% reduced | Q1 2021 8 quarters |
| Pvh Corporation | < 0.1% | 223,813 | 15.8M USD | −42.4% reduced | Q4 2020 9 quarters |
| GS Goldman Sachs | < 0.1% | 45,646 | 15.7M USD | −41.3% reduced | Q2 2022 3 quarters |
| Stag Indl Inc | < 0.1% | 473,221 | 15.3M USD | −23.5% reduced | Q4 2021 5 quarters |
| Karuna Therapeutics Inc | < 0.1% | 76,992 | 15.1M USD | −71.3% reduced | Q3 2022 2 quarters |
| FLEX Flex Ltd. | < 0.1% | 703,900 | 15.1M USD | −69.4% reduced | Q1 2022 4 quarters |
| Cyberark Software Ltd | < 0.1% | 112,800 | 14.6M USD | −50.2% reduced | Q3 2022 2 quarters |
| Vaxcyte Inc | < 0.1% | 302,600 | 14.5M USD | −28.4% reduced | Q3 2022 2 quarters |
| Repligen Corp | < 0.1% | 84,178 | 14.3M USD | −72.6% reduced | Q3 2018 18 quarters |
| Esperion Therapeutics Inc Ne | < 0.1% | 2,277,000 | 14.2M USD | −18.3% reduced | Q2 2022 3 quarters |
| Transalta Corp | < 0.1% | 1,569,275 | 14.0M USD | −13.3% reduced | Q3 2020 10 quarters |
| Ishares TR | < 0.1% | 80,000 | 13.9M USD | −7.9% reduced | Q2 2022 3 quarters |
| Woodward Inc | < 0.1% | 143,200 | 13.8M USD | −14.7% reduced | Q3 2021 6 quarters |
| Performance Food Group Co | < 0.1% | 228,841 | 13.4M USD | −42.7% reduced | Q2 2019 15 quarters |
| Boot Barn HLDGS Inc | < 0.1% | 213,526 | 13.3M USD | −15.7% reduced | Q3 2022 2 quarters |
| Si-Bone Inc | < 0.1% | 951,800 | 12.9M USD | −27.0% reduced | Q1 2022 4 quarters |
| Cerevel Therapeutics Hldng I | < 0.1% | 403,129 | 12.7M USD | −62.8% reduced | Q2 2022 3 quarters |
| Jfrog Ltd | < 0.1% | 595,292 | 12.7M USD | −71.9% reduced | Q3 2021 6 quarters |
| Air Lease Corp | < 0.1% | 328,800 | 12.6M USD | −24.7% reduced | Q2 2022 3 quarters |
| Merit Med Sys Inc | < 0.1% | 177,649 | 12.5M USD | −15.4% reduced | Q2 2021 7 quarters |
| Bill Com HLDGS Inc | < 0.1% | 114,822 | 12.5M USD | −89.3% reduced | Q2 2020 11 quarters |
| FSLR First Solar | < 0.1% | 82,569 | 12.4M USD | −68.4% reduced | Q1 2022 4 quarters |
| ALLE Allegion | < 0.1% | 116,120 | 12.2M USD | −61.7% reduced | Q2 2022 3 quarters |
| APA APA Corporation | < 0.1% | 261,403 | 12.2M USD | −91.6% reduced | Q1 2021 8 quarters |
| VIPS Vipshop | < 0.1% | 893,300 | 12.2M USD | −3.8% reduced | Q2 2022 3 quarters |
| Civitas Resources Inc | < 0.1% | 206,770 | 12.0M USD | −14.4% reduced | Q2 2022 3 quarters |
| Invesco QQQ TR | < 0.1% | 44,600 | 11.9M USD | −22.3% reduced | Q2 2022 3 quarters |
| DLR Digital Realty | < 0.1% | 118,100 | 11.8M USD | −82.6% reduced | Q3 2021 6 quarters |
| Middleby Corp | < 0.1% | 88,000 | 11.8M USD | −46.6% reduced | Q3 2022 2 quarters |
| Equity Residential | < 0.1% | 196,455 | 11.6M USD | −42.6% reduced | Q4 2021 5 quarters |
| CMI Cummins | < 0.1% | 47,576 | 11.5M USD | −45.1% reduced | Q3 2022 2 quarters |
| Smucker J M Co | < 0.1% | 68,500 | 10.9M USD | −77.6% reduced | Q3 2022 2 quarters |
| Radnet Inc | < 0.1% | 565,930 | 10.7M USD | −68.8% reduced | Q2 2020 11 quarters |
| Phreesia Inc | < 0.1% | 325,653 | 10.5M USD | −47.4% reduced | Q1 2022 4 quarters |
| Repay HLDGS Corp | < 0.1% | 1,280,023 | 10.3M USD | −18.9% reduced | Q3 2021 6 quarters |
| Intra-Cellular Therapies Inc | < 0.1% | 194,152 | 10.3M USD | −70.4% reduced | Q3 2022 2 quarters |
| Cameco Corp | < 0.1% | 450,700 | 10.2M USD | −43.2% reduced | Q1 2021 8 quarters |
| NOC Northrop Grumman | < 0.1% | 17,418 | 9.5M USD | −87.7% reduced | Q2 2022 3 quarters |
| Bread Financial Holdings Inc | < 0.1% | 249,821 | 9.4M USD | 0.0% reduced | Q4 2018 17 quarters |
| CSGP CoStar Group | < 0.1% | 121,355 | 9.4M USD | −69.7% reduced | Q1 2022 4 quarters |
| Radius Global Infrastrctre I | < 0.1% | 779,629 | 9.2M USD | −5.8% reduced | Q4 2021 5 quarters |
| Essential Utils Inc | < 0.1% | 192,911 | 9.2M USD | −8.5% reduced | Q3 2021 6 quarters |
| BSX Boston Scientific | < 0.1% | 197,869 | 9.2M USD | −93.2% reduced | Q3 2021 6 quarters |
| FITB Fifth Third Bancorp | < 0.1% | 275,412 | 9.0M USD | −60.7% reduced | Q2 2022 3 quarters |
| Inmode Ltd | < 0.1% | 244,700 | 8.7M USD | −76.2% reduced | Q2 2022 3 quarters |
| Tronox Holdings PLC | < 0.1% | 625,349 | 8.6M USD | −10.0% reduced | Q4 2020 9 quarters |
| The Beauty Health Company | < 0.1% | 907,770 | 8.3M USD | −48.2% reduced | Q2 2022 3 quarters |
| Planet Fitness Inc | < 0.1% | 103,700 | 8.2M USD | −5.5% reduced | Q1 2022 4 quarters |
| Booz Allen Hamilton Hldg Cor | < 0.1% | 77,900 | 8.1M USD | −72.6% reduced | Q2 2021 7 quarters |
| Nexgen Energy Ltd | < 0.1% | 1,808,000 | 8.0M USD | −14.9% reduced | Q3 2022 2 quarters |
| MET MetLife | < 0.1% | 108,066 | 7.8M USD | −82.7% reduced | Q1 2021 8 quarters |
| Viridian Therapeutics Inc | < 0.1% | 260,091 | 7.6M USD | −9.3% reduced | Q1 2021 8 quarters |
| Webster Finl Corp | < 0.1% | 156,327 | 7.4M USD | −33.2% reduced | Q1 2022 4 quarters |
| Nmi HLDGS Inc | < 0.1% | 350,000 | 7.3M USD | −20.2% reduced | Q2 2022 3 quarters |
| Masimo Corp | < 0.1% | 48,500 | 7.2M USD | −76.1% reduced | Q3 2022 2 quarters |
| Veradigm Inc | < 0.1% | 401,900 | 7.1M USD | −59.0% reduced | Q2 2022 3 quarters |
| Halozyme Therapeutics Inc | < 0.1% | 122,000 | 6.9M USD | −59.8% reduced | Q3 2022 2 quarters |
| Healthcare Rlty TR | < 0.1% | 360,095 | 6.9M USD | −55.0% reduced | Q3 2022 2 quarters |
| Kohls Corp | < 0.1% | 260,833 | 6.6M USD | −31.7% reduced | Q1 2022 4 quarters |
| Ryman Hospitality Pptys Inc | < 0.1% | 77,856 | 6.4M USD | −46.2% reduced | Q1 2022 4 quarters |
| Cenovus Energy Inc | < 0.1% | 326,632 | 6.3M USD | −96.1% reduced | Q3 2022 2 quarters |
| Potlatchdeltic Corporation | < 0.1% | 143,800 | 6.3M USD | −47.2% reduced | Q3 2022 2 quarters |
| Perrigo Co PLC | < 0.1% | 181,300 | 6.2M USD | −90.1% reduced | Q2 2022 3 quarters |
| Mdu Res Group Inc | < 0.1% | 195,700 | 5.9M USD | −36.2% reduced | Q1 2022 4 quarters |
| Brp Group Inc | < 0.1% | 225,327 | 5.7M USD | −46.2% reduced | Q3 2021 6 quarters |
| Arch Resources Inc | < 0.1% | 39,120 | 5.6M USD | −44.9% reduced | Q2 2022 3 quarters |
| Bioatla Inc | < 0.1% | 649,680 | 5.4M USD | −15.0% reduced | Q3 2022 2 quarters |
| FIVE9 Inc | < 0.1% | 78,650 | 5.3M USD | −75.1% reduced | Q4 2021 5 quarters |
| Affimed N V | < 0.1% | 4,207,220 | 5.2M USD | −21.9% reduced | Q3 2019 14 quarters |
| Dun & Bradstreet HLDGS Inc | < 0.1% | 424,908 | 5.2M USD | −33.8% reduced | Q3 2022 2 quarters |
| BAC Bank of America | < 0.1% | 151,970 | 5.0M USD | −68.8% reduced | Q1 2022 4 quarters |
| FDS FactSet | < 0.1% | 12,400 | 5.0M USD | −78.6% reduced | Q1 2022 4 quarters |
| MELI MercadoLibre | < 0.1% | 5,719 | 4.8M USD | −93.7% reduced | Q3 2022 2 quarters |
| VICI Vici Properties | < 0.1% | 146,353 | 4.7M USD | −75.3% reduced | Q1 2022 4 quarters |
| Alphatec HLDGS Inc | < 0.1% | 379,300 | 4.7M USD | −58.6% reduced | Q4 2020 9 quarters |
| Antero Midstream Corp | < 0.1% | 432,381 | 4.7M USD | −9.9% reduced | Q2 2022 3 quarters |
| ILMN Illumina, Inc. | < 0.1% | 23,006 | 4.7M USD | −95.4% reduced | Q3 2022 2 quarters |
| FE FirstEnergy | < 0.1% | 107,597 | 4.5M USD | −96.5% reduced | Q2 2022 3 quarters |
| Synovus Finl Corp | < 0.1% | 117,314 | 4.4M USD | −37.5% reduced | Q1 2022 4 quarters |
| Clean Energy Fuels Corp | < 0.1% | 813,551 | 4.2M USD | −39.7% reduced | Q1 2022 4 quarters |
| Regal Rexnord Corporation | < 0.1% | 35,215 | 4.2M USD | −63.1% reduced | Q3 2022 2 quarters |
| Southwest Gas HLDGS Inc | < 0.1% | 67,900 | 4.2M USD | −73.0% reduced | Q4 2021 5 quarters |
| MAR Marriott International | < 0.1% | 27,286 | 4.1M USD | −93.5% reduced | Q3 2022 2 quarters |
| Seres Therapeutics Inc | < 0.1% | 699,600 | 3.9M USD | −25.5% reduced | Q2 2022 3 quarters |
| Axalta Coating Sys Ltd | < 0.1% | 152,440 | 3.9M USD | −73.8% reduced | Q3 2022 2 quarters |
| Allison Transmission HLDGS I | < 0.1% | 90,747 | 3.8M USD | −14.6% reduced | Q3 2022 2 quarters |
| Accolade Inc | < 0.1% | 482,700 | 3.8M USD | −13.5% reduced | Q3 2022 2 quarters |
| Evgo Inc | < 0.1% | 801,110 | 3.6M USD | −14.8% reduced | Q3 2022 2 quarters |
| Angi Inc | < 0.1% | 1,504,814 | 3.5M USD | −19.8% reduced | Q2 2020 11 quarters |
| OPEN Opendoor Technologies | < 0.1% | 3,024,630 | 3.5M USD | −23.1% reduced | Q3 2021 6 quarters |
| Protagonist Therapeutics Inc | < 0.1% | 316,500 | 3.5M USD | −87.5% reduced | Q4 2020 9 quarters |
| Apple Hospitality REIT Inc | < 0.1% | 217,085 | 3.4M USD | −23.5% reduced | Q2 2022 3 quarters |
| Delek US HLDGS Inc New | < 0.1% | 121,000 | 3.3M USD | −73.7% reduced | Q3 2022 2 quarters |
| Nvent Electric PLC | < 0.1% | 84,479 | 3.2M USD | −47.3% reduced | Q3 2022 2 quarters |
| 4D Molecular Therapeutics In | < 0.1% | 139,300 | 3.1M USD | −53.4% reduced | Q3 2022 2 quarters |
| Tripadvisor Inc | < 0.1% | 166,900 | 3.0M USD | −10.2% reduced | Q3 2022 2 quarters |
| Rli Corp | < 0.1% | 21,300 | 2.8M USD | −74.9% reduced | Q3 2022 2 quarters |
| Lexicon Pharmaceuticals Inc | < 0.1% | 1,344,131 | 2.6M USD | −62.8% reduced | Q3 2022 2 quarters |
| Helix Energy Solutions Grp I | < 0.1% | 326,000 | 2.4M USD | −13.0% reduced | Q3 2022 2 quarters |
| Cepton Inc | < 0.1% | 1,813,535 | 2.3M USD | −3.6% reduced | Q1 2022 4 quarters |
| Arrowhead Pharmaceuticals In | < 0.1% | 56,652 | 2.3M USD | −91.5% reduced | Q2 2021 7 quarters |
| DKNG DraftKings | < 0.1% | 189,735 | 2.2M USD | −79.1% reduced | Q1 2022 4 quarters |
| CVNA Carvana | < 0.1% | 447,121 | 2.1M USD | −63.0% reduced | Q1 2022 4 quarters |
| Intercept Pharmaceuticals In | < 0.1% | 166,300 | 2.1M USD | −89.3% reduced | Q3 2021 6 quarters |
| Angiodynamics Inc | < 0.1% | 139,754 | 1.9M USD | −78.7% reduced | Q4 2020 9 quarters |
| Jazz Pharmaceuticals PLC | < 0.1% | 11,800 | 1.9M USD | −97.0% reduced | Q3 2021 6 quarters |
| Enact HLDGS Inc | < 0.1% | 75,000 | 1.8M USD | −32.8% reduced | Q1 2022 4 quarters |
| SPDR Ser TR | < 0.1% | 13,200 | 1.8M USD | −22.4% reduced | Q3 2022 2 quarters |
| Denali Therapeutics Inc | < 0.1% | 64,400 | 1.8M USD | −89.8% reduced | Q3 2022 2 quarters |
| Coty Inc | < 0.1% | 202,717 | 1.7M USD | −81.9% reduced | Q2 2021 7 quarters |
| Berry Global Group Inc | < 0.1% | 24,000 | 1.5M USD | −97.1% reduced | Q2 2021 7 quarters |
| STT State Street Corporation | < 0.1% | 18,520 | 1.4M USD | −86.0% reduced | Q2 2022 3 quarters |
| ROST Ross Stores | < 0.1% | 12,236 | 1.4M USD | −99.3% reduced | Q4 2021 5 quarters |
| Dxc Technology Co | < 0.1% | 51,200 | 1.4M USD | −96.3% reduced | Q3 2022 2 quarters |
| DIS Walt Disney Company (The) | < 0.1% | 15,332 | 1.3M USD | −98.1% reduced | Q4 2021 5 quarters |
| Li-Cycle Holdings Corp | < 0.1% | 279,300 | 1.3M USD | −16.0% reduced | Q1 2022 4 quarters |
| Achilles Therapeutics PLC | < 0.1% | 1,413,809 | 1.3M USD | −32.9% reduced | Q3 2021 6 quarters |
| Talkspace Inc | < 0.1% | 2,050,000 | 1.3M USD | −36.4% reduced | Q2 2022 3 quarters |
| Advanced Drain Sys Inc Del | < 0.1% | 15,000 | 1.2M USD | −91.6% reduced | Q1 2022 4 quarters |
| Employers HLDGS Inc | < 0.1% | 28,000 | 1.2M USD | −7.6% reduced | Q3 2021 6 quarters |
| FFIV F5, Inc. | < 0.1% | 7,900 | 1.1M USD | −97.6% reduced | Q3 2022 2 quarters |
| Arcturus Therapeutics HLDGS | < 0.1% | 64,500 | 1.1M USD | −89.5% reduced | Q1 2022 4 quarters |
| LNT Alliant Energy | < 0.1% | 19,100 | 1.1M USD | −91.5% reduced | Q2 2022 3 quarters |
| Championx Corporation | < 0.1% | 35,000 | 1.0M USD | −80.7% reduced | Q3 2022 2 quarters |
| Immunic Inc | < 0.1% | 714,655 | 1.0M USD | −46.1% reduced | Q3 2021 6 quarters |
| Alx Oncology HLDGS Inc | < 0.1% | 85,000 | 958.0K USD | −77.8% reduced | Q3 2022 2 quarters |
| Lifecore Biomedical Inc | < 0.1% | 141,446 | 916.6K USD | −24.0% reduced | Q4 2021 5 quarters |
| ADSK Autodesk | < 0.1% | 4,901 | 915.9K USD | −96.8% reduced | Q2 2022 3 quarters |
| Transocean Ltd | < 0.1% | 193,108 | 880.6K USD | −65.7% reduced | Q1 2022 4 quarters |
| REG Regency Centers | < 0.1% | 13,900 | 868.8K USD | −86.6% reduced | Q3 2022 2 quarters |
| Aligos Therapeutics Inc | < 0.1% | 905,896 | 863.2K USD | −1.2% reduced | Q3 2021 6 quarters |
| Aadi Bioscience Inc | < 0.1% | 66,066 | 847.6K USD | −88.4% reduced | Q1 2022 4 quarters |
| Ishares TR | < 0.1% | 20,100 | 761.8K USD | −94.6% reduced | Q2 2022 3 quarters |
| Globalstar Inc | < 0.1% | 498,500 | 663.0K USD | −78.8% reduced | Q3 2022 2 quarters |
| Childrens Pl Inc New | < 0.1% | 18,200 | 662.8K USD | −91.3% reduced | Q1 2019 16 quarters |
| X4 Pharmaceuticals Inc | < 0.1% | 650,000 | 645.5K USD | −74.5% reduced | Q4 2021 5 quarters |
| Mediaalpha Inc | < 0.1% | 64,000 | 636.8K USD | −66.7% reduced | Q3 2021 6 quarters |
| Northwestern Corp | < 0.1% | 10,600 | 629.0K USD | −93.1% reduced | Q2 2022 3 quarters |
| Blackline Inc | < 0.1% | 8,700 | 585.2K USD | −91.4% reduced | Q3 2022 2 quarters |
| Fulgent Genetics Inc | < 0.1% | 18,800 | 559.9K USD | −88.3% reduced | Q3 2021 6 quarters |
| Applied Therapeutics Inc | < 0.1% | 719,938 | 547.2K USD | −58.1% reduced | Q1 2020 12 quarters |
| CBRE CBRE Group | < 0.1% | 6,800 | 523.3K USD | −95.5% reduced | Q1 2022 4 quarters |
| Albireo Pharma Inc | < 0.1% | 24,200 | 523.0K USD | −69.0% reduced | Q3 2022 2 quarters |
| Ishares TR | < 0.1% | 10,000 | 498.2K USD | −50.0% reduced | Q1 2020 12 quarters |
| Wave Life Sciences Ltd | < 0.1% | 63,600 | 445.2K USD | −93.9% reduced | Q3 2022 2 quarters |
| Century Therapeutics Inc | < 0.1% | 82,100 | 421.2K USD | −50.3% reduced | Q4 2021 5 quarters |
| Buckle Inc | < 0.1% | 9,100 | 412.7K USD | −96.5% reduced | Q3 2022 2 quarters |
| Sony Group Corporation | < 0.1% | 5,137 | 391.9K USD | −67.3% reduced | Q2 2022 3 quarters |
| Myriad Genetics Inc | < 0.1% | 26,800 | 388.9K USD | −93.4% reduced | Q1 2022 4 quarters |
| Brc Inc | < 0.1% | 60,900 | 372.1K USD | −92.3% reduced | Q3 2022 2 quarters |
| Arrival | < 0.1% | 2,180,000 | 347.7K USD | −15.5% reduced | Q3 2022 2 quarters |
| Sweetgreen Inc | < 0.1% | 36,700 | 314.5K USD | −69.8% reduced | Q3 2022 2 quarters |
| Bjs Restaurants Inc | < 0.1% | 10,700 | 282.3K USD | −96.0% reduced | Q2 2022 3 quarters |
| Arcelormittal SA Luxembourg | < 0.1% | 10,445 | 273.9K USD | −45.0% reduced | Q2 2022 3 quarters |
| Aeva Technologies Inc | < 0.1% | 189,600 | 257.9K USD | −51.9% reduced | Q3 2022 2 quarters |
| Centessa Pharmaceuticals PLC | < 0.1% | 79,700 | 247.1K USD | −32.3% reduced | Q2 2021 7 quarters |
| Gh Research PLC | < 0.1% | 24,600 | 239.1K USD | −87.9% reduced | Q4 2021 5 quarters |
| Foghorn Therapeutics Inc | < 0.1% | 33,000 | 210.5K USD | −91.5% reduced | Q4 2021 5 quarters |
| Blue Owl Capital Inc | < 0.1% | 19,500 | 206.7K USD | −94.7% reduced | Q3 2022 2 quarters |
| Electronic Arts Inc | < 0.1% | 1,526 | 186.4K USD | −98.6% reduced | Q2 2021 7 quarters |
| Lincoln Natl Corp Ind | < 0.1% | 5,347 | 164.3K USD | −97.8% reduced | Q3 2021 6 quarters |
| First Watch Restaurant Group | < 0.1% | 10,504 | 142.1K USD | −90.6% reduced | Q2 2022 3 quarters |
| VTRS Viatris | < 0.1% | 12,347 | 137.4K USD | −99.3% reduced | Q3 2022 2 quarters |
| Ares Acquisition Corporation | < 0.1% | 275,000 | 128.2K USD | −14.1% reduced | Q1 2022 4 quarters |
| Tusimple HLDGS Inc | < 0.1% | 72,097 | 118.2K USD | −53.3% reduced | Q3 2021 6 quarters |
| Duck Creek Technologies Inc | < 0.1% | 7,700 | 92.8K USD | −81.8% reduced | Q2 2022 3 quarters |
| PEP PepsiCo | < 0.1% | 441 | 79.7K USD | −99.9% reduced | Q3 2022 2 quarters |
| Neoleukin Therapeutics Inc | < 0.1% | 136,675 | 69.6K USD | −93.4% reduced | Q4 2019 13 quarters |
| Chindata Group HLDGS Ltd | < 0.1% | 7,200 | 57.4K USD | −89.9% reduced | Q2 2022 3 quarters |
| UNH UnitedHealth Group | < 0.1% | 96 | 50.9K USD | −99.9% reduced | Q3 2022 2 quarters |
| Aurora Innovation Inc | < 0.1% | 30,000 | 36.3K USD | −59.6% reduced | Q4 2021 5 quarters |
| COIN Coinbase | < 0.1% | 469 | 16.6K USD | −97.8% reduced | Q2 2022 3 quarters |
| Sonic Automotive Inc | < 0.1% | 200 | 9.9K USD | −99.5% reduced | Q3 2022 2 quarters |
| D-Wave Quantum Inc | < 0.1% | 33,333 | 3.5K USD | −41.2% reduced | Q3 2022 2 quarters |
| Adicet Bio Inc | < 0.1% | 300 | 2.7K USD | −99.7% reduced | Q1 2021 8 quarters |
| Churchill Capital Corp Vii | < 0.1% | 14,000 | 692.0 USD | −6.7% reduced | Q1 2022 4 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 400 option positions, value of the underlying shares as reported 2.9B USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- SPDR S&P 500 ETF TR Put 479.8M USD
- SPDR S&P 500 ETF TR Call 266.2M USD
- Humana Put 196.9M USD
- UnitedHealth Group Put 196.8M USD
- Invesco Db Multi-Sector Comm Call 90.7M USD
- Caterpillar Inc. Put 70.4M USD
- Select Sector SPDR TR Put 57.4M USD
- IBM Put 53.6M USD
- Medical Pptys Trust Inc Put 51.2M USD
- AstraZeneca Call 49.9M USD
Plus 52 positions in convertible bonds and bonds worth 472.4M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Novavax Inc principal 29.9M USD 29.8M USD
- Ringcentral Inc principal 27.7M USD 23.9M USD
- Unity Software Inc principal 30.0M USD 22.6M USD
- Splunk Inc principal 21.0M USD 20.3M USD
- Spotify USA Inc principal 24.5M USD 19.8M USD
- Docusign Inc principal 18.5M USD 17.5M USD
- Dish Network Corporation principal 27.0M USD 17.3M USD
- Dish Network Corporation principal 19.0M USD 17.1M USD
- Splunk Inc principal 18.0M USD 17.0M USD
- Sarepta Therapeutics Inc principal 9.0M USD 16.8M USD
Breakdown by sector
- Technology 12.1%
- Financials 7.3%
- Consumer Discretionary 7.0%
- Industrials 6.5%
- Health Care 5.7%
- Communication Services 5.4%
- Utilities 3.5%
- Consumer Staples 2.5%
- Energy 2.3%
- Materials 1.2%
- Real Estate 0.7%
- not in our coverage 45.9%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors